An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

NYU Langone Medical Center, New York

Memorial Sloan Kettering Nassau, New York

Local Institution, Marseille

UPMC Cancer Center, Pittsburgh

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Lutherville

Local Institution, Besançon

Clinica Universidad de Navarra, Pamplona

H. Lee Moffitt Cancer Center, Tampa

Local Institution, Rennes

Universitaetsklinikum Essen, Essen

University Of Chicago, Chicago

Md Anderson, Houston

Stanford University School Of Medicine, Palo Alto

Local Institution, Villejuif

Providence Portland Medical Center, Portland

Dana Farber Cancer Institute, Boston

Dana-Farber Cancer Institute, Boston